Two or More Morbidities at Psoriasis Onset May Indicate Increased PsA RiskFebruary 16, 2024Psoriatic Arthritis
Serum Biomarkers Identifying Guselkumab Responders Among TNFi-Inadequate Responders with PsAFebruary 16, 2024Psoriatic Arthritis
Tofacitinib Effective Across Multiple PsA Domains in The Real WorldFebruary 16, 2024Psoriatic Arthritis
Meta-analysis Confirms Promising Efficacy-Safety Profile of Risankizumab in PsAFebruary 16, 2024Psoriatic Arthritis
Rheumatology NewsPretreatment Lab Testing for Chronic Skin Diseases Diverges From GuidelinesFebruary 15, 2024Psoriatic Arthritis
Rheumatology NewsOral IL-23 Inhibitor Calms Moderate to Severe PsoriasisFebruary 12, 2024Psoriatic Arthritis
Rheumatology NewsComorbidities and Disease Type Weigh Heavily in Pregnancy Outcomes of Immune-Mediated Inflammatory DiseasesFebruary 8, 2024Rheumatoid ArthritisLupus & Connective Tissue DiseasesPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitisVasculitis
Rheumatology NewsReview Finds No Short-term MACE, VTE risk with JAK Inhibitors For DermatosesFebruary 5, 2024Mixed TopicsPediatricsPsoriatic Arthritis
Rheumatology NewsA Paradox? Higher Male Fertility Seen With Inflammatory ArthritisJanuary 25, 2024Rheumatoid ArthritisPsoriatic ArthritisSpondyloarthropathiesAnkylosing spondylitis
